Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living with diabetes, obesity, and growth disorders is a welcome step forward. The new PenCycle programme ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, ...

Novo Nordisk A/S ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin ...

Danish drugmaker Novo Nordisk owns the patent to semaglutide and uses it ... I can't remember what it is, it's you, literally ...

Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide ...

Almost exactly a year after launching its Obesity Association, the American Diabetes Association (ADA) has recruited Novo ...

Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...

The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...

As of June 4 at 8:42:51 AM CST. Market Open.

As of 12:44:21 pm GMT-4. Market open.